LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 59.85 | 27.76 | 308 | 6062 | 0.0508 | 0.3630 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 59.85 | 27.76 | 6881 | 6062 | 1.1350 | 1.0329 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 59.85 | 27.76 | 4206 | 6062 | 0.6938 | 0.9081 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 59.85 | 27.76 | 4635 | 6062 | 0.7645 | 0.9321 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 61.56 | 27.76 | 326 | 6217 | 0.0524 | 0.3710 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 61.56 | 27.76 | 7192 | 6217 | 1.1568 | 1.0377 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 61.56 | 27.76 | 3975 | 6217 | 0.6394 | 0.8886 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 61.56 | 27.76 | 4752 | 6217 | 0.7643 | 0.9323 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 63.26 | 27.76 | 291 | 6465 | 0.0450 | 0.3483 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 63.26 | 27.76 | 7437 | 6465 | 1.1502 | 1.0359 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 63.26 | 27.76 | 4157 | 6465 | 0.6429 | 0.8908 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 63.26 | 27.76 | 4893 | 6465 | 0.7568 | 0.9304 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 64.97 | 27.76 | 291 | 6656 | 0.0437 | 0.3461 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 64.97 | 27.76 | 7711 | 6656 | 1.1584 | 1.0375 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 64.97 | 27.76 | 3900 | 6656 | 0.5859 | 0.8692 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 64.97 | 27.76 | 4985 | 6656 | 0.7489 | 0.9282 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 66.67 | 27.76 | 249 | 6695 | 0.0372 | 0.3195 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 66.67 | 27.76 | 7966 | 6695 | 1.1897 | 1.0444 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 66.67 | 27.76 | 3249 | 6695 | 0.4852 | 0.8254 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 66.67 | 27.76 | 5098 | 6695 | 0.7614 | 0.9323 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 68.37 | 27.76 | 246 | 6879 | 0.0358 | 0.3157 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 68.37 | 27.76 | 8195 | 6879 | 1.1913 | 1.0445 | MN20160318_Q01 | I15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 68.37 | 27.76 | 3346 | 6879 | 0.4864 | 0.8267 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 68.37 | 27.76 | 5196 | 6879 | 0.7553 | 0.9307 | MN20160318_Q01 | M03 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 70.08 | 27.76 | 220 | 6849 | 0.0321 | 0.2976 | MN20160318_Q01 | I15 |